Melvin Rothberg, Director at Lotus Pharmaceuticals, Inc. (LTUS), sold 30,000 shares at $1.01 ($30K) on 2008-01-02, disclosed to the SEC on 2008-01-09.
Open-market sale of $30k LTUS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.